Literature DB >> 11888053

Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection.

Frank Schönberger1, Georg Heinkele, Thomas E Mürdter, Stefanie Brenner, Ulrich Klotz, Ute Hofmann.   

Abstract

A simple method is described for the determination of the cyclooxygenase-2 specific inhibitor celecoxib in human serum by HPLC using the demethylated analogue as internal standard. After protein precipitation with acetonitrile, samples were extracted with chloroform. Separation was achieved on a Prontosil C18 AQ column (150x3 mm I.D., 3-microm particle size) at a flow-rate of 0.35 ml/min using water-acetonitrile (40:60, v/v) as the mobile phase. Using fluorescence detection with excitation at 240 nm and emission at 380 nm, the limit of quantification was 12.5 ng/ml for a sample size of 0.5 ml of serum. The assay was linear in the concentration range of 12.5-1500 ng/ml and showed good accuracy and reproducibility. At all concentrations intra- and inter-assay variabilities were below 11% with less than 9% error. The method was applied to the determination of celecoxib for pharmacokinetic studies in man.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888053     DOI: 10.1016/s1570-0232(01)00588-8

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.

Authors:  Melania Dovizio; Stefania Tacconelli; Emanuela Ricciotti; Annalisa Bruno; Thorsten Jürgen Maier; Paola Anzellotti; Luigia Di Francesco; Paola Sala; Stefano Signoroni; Lucio Bertario; Dan A Dixon; John A Lawson; Dieter Steinhilber; Garret A FitzGerald; Paola Patrignani
Journal:  J Pharmacol Exp Ther       Date:  2012-01-19       Impact factor: 4.030

2.  Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib.

Authors:  Stefanie S Brenner; Charlotte Herrlinger; Karin Dilger; Thomas E Mürdter; Ute Hofmann; Claudia Marx; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

4.  Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women.

Authors:  Edward R Sauter; Wenyi Qin; John E Hewett; Rachel L Ruhlen; John T Flynn; George Rottinghaus; Yin-Chieh Chen
Journal:  BMC Cancer       Date:  2008-02-11       Impact factor: 4.430

5.  uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.

Authors:  Wenyi Qin; Weizhu Zhu; John E Hewett; George Rottinghaus; Yin-Chieh Chen; John T Flynn; Beth Kliethermes; Ferdinando Mannello; Edward R Sauter
Journal:  BMC Cancer       Date:  2008-10-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.